Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis (Record no. 72564)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00658cam a2200217 4500 |
| 001 - CONTROL NUMBER | |
| control field | CN101573 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120401t2020 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 02694727 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Young Ho Lee |
| 240 ## - UNIFORM TITLE | |
| Uniform title | <a href="Journal of Clinical Pharmacy and Therapeutics">Journal of Clinical Pharmacy and Therapeutics</a> |
| 245 ## - TITLE STATEMENT | |
| Title | Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Date of publication, distribution, etc. | 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 674-681 |
| 500 ## - GENERAL NOTE | |
| General note | Serial |
| 500 ## - GENERAL NOTE | |
| General note | 32495356 |
| 500 ## - GENERAL NOTE | |
| General note | 8006872 |
| 500 ## - GENERAL NOTE | |
| General note | 45 |
| 500 ## - GENERAL NOTE | |
| General note | 4 |
| 500 ## - GENERAL NOTE | |
| General note | https://doi.org/10.1111/jcpt.13142 |
| 500 ## - GENERAL NOTE | |
| General note | Document_8006872_13384.pdf |
No items available.